Skip to Content


Zachary Brennan, citing Rachel E. Sachs (Academic Fellow Alumna)
Regulatory Affairs Professionals Society (RAPS)
February 27, 2017

Read the Full Round-Up

[...] The bill has drawn criticism from industry groups and others who say such independent audits would be overly burdensome for industry and that the $2500 threshold might include too many drugs as other states have included a $10,000 threshold, though other experts think the legislation is a step in the right direction. [...]

Read the Full Round-Up

Tags

health care finance   health law policy   pharmaceuticals   public health   rachel sachs   regulation